Back to
Skandinaviska Enskilda Banken AB (publ)
ORTX2 quarters
Position history for
Skandinaviska Enskilda Banken AB (publ)'s holdings in ORCHARD THERAPEUTICS PLC
As of its Q4 2023 13F, Skandinaviska Enskilda Banken AB (publ) held 140,500 shares of ORTX (Orchard Therapeutics), worth $2.3M.
Final Value
$0
Final Shares
0
Total Value Change
-$2.3M
Total Shares Change
-140,500
Quarter-by-Quarter History
Other major holders of ORTX: FEDERATED HERMES, INC., LMR Partners LLP, TUDOR INVESTMENT CORP ET AL